European Society for Medical Oncology (ESMO) releases new patient guide in breast cancer

The European Society for Medical Oncology (ESMO) has released a new edition of the ESMO Patient Guide in Breast Cancer, as part of their guideline series. 


Updates to the new edition include:

• section on locally-advanced disease
• new section on sentinel lymph node biopsy (SLNB)
• new drugs (neratinib, olaparib, and talazoparib) and associated treatment algorithms
• section on special populations (BRCA-associated disease, pregnancy, young women, elderly patients, men)
• Section on supplementary interventions (supportive and palliative care, survivorship, end-of-life care

 To access the new guide, click here.